Drug-labels.com

Priva-Irbesartan: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
75 mg, 150 mg, 300 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Priva-Irbesartan

ABOUT THIS MEDICATION

What the medication is used for:

  • Irbesartan lowers high blood pressure
  • If you have high blood pressure, type 2

    diabetes and kidney disease, Irbesartan may help to protect kidney function

What it does:

Irbesartan is an angiotensin receptor blockers (ARB). You can recognize an ARB because its medicinal ingredient ends in “-SARTAN”.

This medicine does not cure your disease. It helps to control it. Therefore, it is important to continue taking Priva-IRBESARTAN regularly even if you feel fine.

When it should not be used:

Do not take Priva-IRBESARTAN if you:

  • Are allergic to irbesartan or to any non-

    medicinal ingredient in the formulation.

  • Have experienced an allergic reaction

    (angioedema) with swelling of the hands, feet, or ankles, face, lips, tongue, throat, or sudden difficulty breathing or swallowing, to any ARB. Be sure to tell your doctor, nurse, or pharmacist that this has happened to you.

  • Have diabetes or kidney disease and are already

    taking:

    • a blood pressure-lowering medicine that

      contains aliskiren (such as Rasilez)

    • an angiotensin converting enzyme (ACE)

      inhibitor. You can recognize ACE

      inhibitors because their medicinal ingredient ends in ‘PRIL’

      • Are pregnant or intend to become pregnant.

        Taking Priva-IRBESARTAN during pregnancy can cause injury and even death to your baby.

      • Are breastfeeding. It is possible that irbesartan passes into breast milk.
      • Have one of the following rare hereditary diseases:

        • Galactose intolerance
        • Lapp lactase deficiency
        • Glucose-galactose malabsorption Because lactose is a non-medicinal ingredient in Priva-IRBESARTAN.

Irbesartan is not recommended for use in children and adolescents (under the age of 18 years).

What the medicinal ingredient is:

Irbesartan.

What the nonmedicinal ingredients are:

Lactose monohydrate, colloidal anhydrous silica, microcrystalline cellulose, croscarmellose sodium, hypromellose, starch pregelatinized, magnesium stearate, titanium dioxide and macrogol.

What dosage forms it comes in:

Oval tablets (white to off white); 75 mg, 150 mg, and 300 mg.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions - Pregnancy

Priva-IRBESARTAN should not be used during pregnancy. If you discover that you are pregnant while taking irbesartan, stop the medication and contact your physician as soon as possible.

BEFORE you use Priva-IRBESARTAN tablets talk to your doctor, nurse or pharmacist if you:

  • Have experienced an allergic reaction to any drug used to lower blood pressure, including angiotensin converting enzyme (ACE) inhibitors.
  • Have narrowing of an artery or a heart valve.
  • Have had a heart attack or stroke.
  • Have heart failure.
  • Have diabetes, liver or kidney disease.
  • Are on dialysis.
  • Are dehydrated or suffer from excessive

    vomiting, diarrhea, or sweating.

  • Are taking a salt substitute that contains

    potassium, potassium supplements, or a potassium-sparing diuretic (a specific kind of “water pill” that makes your body keep potassium).

  • Are on a low-salt diet.
  • Are taking a medicine that contains aliskiren,

    such as Rasilez, used to lower high blood pressure. The combination with irbesartan is not recommended.

  • Are taking an angiotensin converting enzyme

    (ACE) inhibitor. The combination with irbesartan is not recommended.

  • Are taking a medicine that contains lithium.

    The combination with irbesartan is not recommended.

  • Are less than 18 years old.

Driving and using machines: Before you perform tasks which may require special attention, wait until you know how you respond to irbesartan. Dizziness, lightheadness, or fainting can especially occur after the dose and when the dose is increased.

Please remember:

  • If you are to undergo any surgery or receive

    anaesthetics, you should make sure your doctor knows that you are taking Priva-IRBESARTAN.

INTERACTIONS WITH THIS MEDICATION

As with most medicines, interactions with other drugs are possible. Tell your doctor, nurse, or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines.

The following may interact with Irbesartan:

  • Agents increasing serum potassium, such as a salt substitute that contains potassium, potassium supplements, or a potassium-sparing diuretic (a specific kind of “water pill”).
  • Lithium used to treat bipolar disease.
  • Nonsteroidal anti-inflammatory drugs

    (NSAIDs), used to reduce pain and swelling. Examples include ibuprofen, naproxen, and celecoxib.

  • Blood pressure-lowering drugs, including diuretics (“water pills”), aliskiren-containing products (e.g. RASILEZ®), or angiotensin converting enzyme (ACE) inhibitors.
  • Certain medications tend to increase your blood pressure, for example, preparations for appetite control, asthma, colds, coughs, hay fever and sinus problems.

PROPER USE OF THIS MEDICATION

Take Priva-IRBESARTAN tablets exactly as prescribed. It is recommended to take your dose at about the same time every day.

Do not stop taking your medication without having first informed your doctor.

Usual Adult Dose:

High Blood Pressure (hypertension) including in patients with Type 2 Diabetes Mellitus:

Recommended Initial Dose: 150 mg once daily.

Your doctor can increase the dosage to 300 mg once daily when required.

Priva-IRBESARTAN tablets may be taken with or without food.

Remember that your doctor has prescribed this medicine only for you. Never give it to anyone else.

Overdose:

If you think you have taken too much Irbesartan contact your doctor, nurse, pharmacist, hospital emergency department or regional Poison control Centre immediately, even if there are no symptoms.

Missed Dose:

If you have forgotten to take your dose during the day, carry on with the next one at the usual time. Do not double dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Side effects may include:

  • dizziness
  • drowsiness, insomnia, being tired
  • rash
  • diarrhea, vomiting
  • headache
  • back or leg pain, muscle cramps
  • Lightheadedness
  • Ringing in the ears.

If any of these affects you severely, tell your doctor, nurse or pharmacist.

Irbesartan can cause abnormal blood test results. Your doctor will decide when to perform blood tests and will interpret the results.

S

ERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and seek immediate medical help
Only if severeIn all cases

Increased levels of potassium in the blood: irregular

heartbeats, muscle weakness and generally feeling unwell

√
Low blood pressure: Dizziness/ Fainting/ Light-headedness√

Jaundice (Liver

disorder): yellowing of the skin or eyes, dark urine, abdominal pain, nausea, vomiting, loss of appetite

√

Kidney Disorder:

change in frequency of urination, nausea, vomiting, swelling of extremities, fatigue

√

Rhabdomyolysis:

muscle pain that you cannot explain, muscle tenderness or

weakness, dark brown urine

√

Allergic Reaction:

rash, hives, swelling of the face, lips, tongue or throat, difficulty

swallowing or

breathing

√

Decreased Platelets:

bruising, bleeding, fatigue and weakness

√

This is not a complete list of side effects. If you have any unexpected effects while taking Priva-IRBESARTAN tablets, contact your doctor or pharmacist.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

Report online at ww.healthcanada.gc.ca/medeffect Call toll-free at 1-866-234-2345

Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program

    Health Canada

    Postal Locator 0701E Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the Management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

HOW TO STORE IT

Store Priva-IRBESARTAN tablets at room temperature (15 to 30°C).

Keep this medication out of the reach and sight of children.

MORE INFORMATION

This document, plus the full product monograph prepared for health professionals, can be found by contacting Pharmapar Inc.

Pharmapar Inc.

100-5950, Ch. de la Côte-de-Liesse

Mont-Royal, QC

H4T 1E2

Phone : (514) 731-2003; Fax: (514) 731-2004

Date of Preparation: March 15, 2016

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02446499

Revision date stated in the text: March 15, 2016

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Priva-Irbesartan

Rx or OTC
Prescription (Rx)?
DIN 02446499, 02446502, 02446510
Schedule(s) PRESCRIPTION
Active ingredient(s) Irbesartan
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09C Angiotensin II receptor blockers (ARBs), plain
        1. C09CA Angiotensin II receptor blockers (ARBs), plain
          1. C09CA04 Irbesartan
Company PHARMAPAR INC
Current status Cancelled Post Market
Current status date July 29, 2022
Strengths and forms
DIN Strength Dosage form(s) Current status
02446499 75 MG Tablet Cancelled Post Market July 29, 2022
02446502 150 MG Tablet Cancelled Post Market July 29, 2022
02446510 300 MG Tablet Cancelled Post Market July 29, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.